Insider Trading: Enzo Biochem Inc (ENZ)
ENZ on New York Consolidated
2.28USD
17 May 2013
2.28USD
17 May 2013
Price Change (% chg)
$0.03 (+1.33%)
$0.03 (+1.33%)
Prev Close
$2.25
$2.25
Open
$2.25
$2.25
Day's High
$2.28
$2.28
Day's Low
$2.25
$2.25
Volume
67,864
67,864
Avg. Vol
102,803
102,803
52-wk High
$3.16
$3.16
52-wk Low
$1.33
$1.33
All Insider Trades
| Trading Date | Name | Title | Type | Shares Traded | Price |
|---|---|---|---|---|---|
| 25 Jan 2012 | CRESCENZO ANDREW R |
Officer | Buy | 12,000 | $0.00 |
| 25 Jan 2012 | GOLDBERG DAVID C |
Officer | Buy | 10,000 | $0.00 |
| 25 Jan 2012 | WHITELEY ANDREW P |
Officer | Buy | 5,000 | $0.00 |
| 15 Nov 2011 | RABBANI ELAZAR |
Chief Executive Officer | Buy | 3,600 | $2.29 |
| 15 Nov 2011 | RABBANI ELAZAR |
Chief Executive Officer | Buy | 2,800 | $2.30 |
| 15 Nov 2011 | WEINER BARRY W |
President | Buy | 4,818 | $2.30 |
| 15 Nov 2011 | RABBANI ELAZAR |
Chief Executive Officer | Buy | 5,700 | $2.29 |
| 15 Nov 2011 | WEINER BARRY W |
President | Buy | 2,182 | $2.27 |
| 15 Nov 2011 | WEINER BARRY W |
President | Buy | 2,000 | $2.32 |
| 15 Nov 2011 | WEINER BARRY W |
President | Buy | 6,000 | $2.28 |
| 15 Nov 2011 | RABBANI ELAZAR |
Chief Executive Officer | Buy | 600 | $2.28 |
| 15 Nov 2011 | WEINER BARRY W |
President | Buy | 3,000 | $2.29 |
| 15 Nov 2011 | RABBANI ELAZAR |
Chief Executive Officer | Buy | 6,600 | $2.28 |
| 15 Nov 2011 | RABBANI ELAZAR |
Chief Executive Officer | Buy | 600 | $2.30 |
| 15 Nov 2011 | WEINER BARRY W |
President | Buy | 2,000 | $2.25 |
| 15 Nov 2011 | RABBANI ELAZAR |
Chief Executive Officer | Buy | 100 | $2.30 |
| 1 Jun 2011 | BASS HERBERT B |
Officer | Buy | 3,000 | $0.00 |
| 1 Jun 2011 | GOLDBERG DAVID C |
Officer | Buy | 10,000 | $0.00 |
| 1 Jun 2011 | WHITELEY ANDREW P |
Officer | Buy | 5,000 | $0.00 |
| 1 Jun 2011 | CRESCENZO ANDREW R |
Officer | Buy | 12,000 | $0.00 |
Institutional Holders
| % Shares Owned: | 31.68% |
| # of Holders: | 91 |
| Total Shares Held: | 15,008,290 |
| 3 Mo. Net Change: | -17,308 |
| # New Positions: | 12 |
| # Closed Positions: | 5 |
| # Increased Positions: | 32 |
| # Reduced Positions: | 28 |
| # Net Buyers: | 4 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Barry Weiner |
62 | 2009 | President, Chief Financial Officer, Principal Accounting Officer, Treasurer, Director |
Elazar Rabbani |
69 | 2009 | Chairman of the Board, Chief Executive Officer, Secretary |
Andrew Crescenzo |
56 | 2006 | Senior Vice President - Finance |
Herbert Bass |
64 | 1989 | Vice President - Finance |
Paul O'Brien |
50 | 2009 | Vice President - Global Human Resources |
David Goldberg |
55 | 2011 | Vice President - Corporate Development; Interim General Manager of Enzo Clinical Labs |
Andrew Whiteley |
54 | 2011 | Chief Operating Officer of Enzo Life Sciences, Inc., |
Bernard Kasten |
66 | 2011 | Lead Independent Director |
Dov Perlysky |
50 | 2012 | Director |
Gregory Bortz |
43 | 2010 | Independent Director |
Steve Anreder |
IR Contact Officer |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
